{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["47(5)"],"submitter":["Flesch BK"],"pubmed_abstract":["<h4>Background and aims</h4>Only little is known about blood groups other than ABO blood groups and Rhesus factors in Arabian countries and Iran. During the last years, increased migration to Central Europe has put a focus on the question how to guarantee blood supply for patients from these countries, particularly because hemoglobinopathies with the need of regular blood support are more frequent in patients from that region. Therefore, blood group allele frequencies should be determined in individuals from Arabian countries and Iran by molecular typing and compared to a German rare donor panel.<h4>Methods</h4>1,111 samples including 800 individuals from Syria, 147 from Iran, 123 from the Arabian Peninsula, and 41 from Northern African countries were included in a MALDI-TOF MS assay to de"],"journal":["Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie"],"pagination":["396-408"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7590766"],"repository":["biostudies-literature"],"pubmed_title":["Molecular Blood Group Screening in Donors from Arabian Countries and Iran Using High-Throughput MALDI-TOF Mass Spectrometry and PCR-SSP."],"pmcid":["PMC7590766"],"pubmed_authors":["Ochmann O","Zeiler T","Scherer V","Just B","Steitz M","Opitz A","Flesch BK","Janson A"],"additional_accession":[]},"is_claimable":false,"name":"Molecular Blood Group Screening in Donors from Arabian Countries and Iran Using High-Throughput MALDI-TOF Mass Spectrometry and PCR-SSP.","description":"<h4>Background and aims</h4>Only little is known about blood groups other than ABO blood groups and Rhesus factors in Arabian countries and Iran. During the last years, increased migration to Central Europe has put a focus on the question how to guarantee blood supply for patients from these countries, particularly because hemoglobinopathies with the need of regular blood support are more frequent in patients from that region. Therefore, blood group allele frequencies should be determined in individuals from Arabian countries and Iran by molecular typing and compared to a German rare donor panel.<h4>Methods</h4>1,111 samples including 800 individuals from Syria, 147 from Iran, 123 from the Arabian Peninsula, and 41 from Northern African countries were included in a MALDI-TOF MS assay to de","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Oct","modification":"2025-04-04T22:27:12.49Z","creation":"2020-11-19T16:55:10Z"},"accession":"S-EPMC7590766","cross_references":{"pubmed":["33173458"],"doi":["10.1159/000505495"]}}